New pain block could cut opioid use after back surgery

NCT ID NCT06869889

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tests whether a targeted nerve block (retrolaminar block) provides better pain relief after lumbar discectomy than the standard method of injecting pain medicine into the surgical wound. 130 adults having elective single-level herniated disc surgery will be randomly assigned to one of the two techniques. The goal is to see which approach reduces the need for rescue pain medication and total opioid use in the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

local anesthetic mixture (bupivacaine)

What this could lead to

If the retrolaminar block works better, it could offer patients a more effective way to control pain after back surgery, reducing the need for opioids and speeding up recovery.

What could go wrong

This is a small, early-stage trial (130 people) comparing two common techniques. The results may not apply to everyone, and there is always a risk that the block does not provide better pain relief than the simpler infiltration method.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia lumbar disk herniation, susceptibility to pain agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zagazig university hospital

    Zagazig, Egypt